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1. Introduction  
The histamine H4 receptor (H4R) is the most recently identified of the four histamine 
receptors (H1R–H4R), and belongs to the same G-protein-coupled receptor (GPCR) family. 
The amino acid sequence of H4R shares approximately 26%, 27%, and 58% homology with 
H1R, H2R, and H3R, respectively, in the transmembrane regions (Nguyen et al., 2001). 
Furthermore, H4R couples to Gi/o proteins and shows 103- to 104-fold higher ligand affinity 
than H1R and H2R (Thurmond et al., 2008). 
Several organs express H4R, and immune tissues such as the spleen, thymus, bone marrow, 
and leukocytes have a wide range of expression levels (Oda et al., 2000). It has been reported 
that chemotaxis of mast cells and eosinophils is stimulated by histamine via H4R; the receptor 
is therefore attractive as a new target of research into allergic diseases (de Esch et al., 2005). 
2. Expression of H4R in synovial tissue in rheumatoid arthritis  
A role for histamine has been implicated in rheumatoid arthritis (RA). RA consists mainly of 
synovial tissue inflammation that may be dispersed throughout the body, but its molecular 
etiology remains unclear. Macrophage infiltration and excessive formation of fibroblasts 
cause a variety of cytokines to be secreted from synovial membranes in patients with RA, 
and this in turn stimulates osteolytic activity (Sweeney & Firestein, 2004). There is evidence 
of a significant increase in histamine concentration in synovial samples from patients with 
RA (Frewin et al., 1986). These observations suggest a potentially significant role of H4R in 
the cause, progression, and treatment of RA. 
The presence of H1R and H2R in human synovial cell culture (HSCC) has been clearly shown 
by ligand-binding experiments (Nagata, 1991). However, there has been no definitive 
evidence or conclusive reports of the similar presence of H3R or H4R. Therefore, utilizing 
our expertise in reverse transcription polymerase chain reaction (RT-PCR) techniques, we 
examined the H4R-specific mRNA expression in HSCC obtained from 11 RA patients who 
underwent artificial knee-replacement surgery (Ikawa et al., 2005). 
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After excising the synovial membrane specimen under aseptic conditions, the sample was 
treated with collagenase and trypsin solution to separate it into single cells. The cells were 
cultured for 2 weeks in medium containing fetal bovine serum. When the culture reached 
confluence, the cells were harvested and all RNA extracted. Analysis of the expression of the 
4 subtypes of histamine receptor-specific mRNA in 2 patients with RA (RA1 and RA2) by 
RT-PCR showed that, under the experimental conditions, H1R-, H2R-, and H4R-specific 
mRNAs were expressed, but H3R-specific mRNA was not (Fig. 1). Expression of H4R-
specific mRNA was confirmed in all 11 samples (RA1–RA11; Fig. 2). Notably, the intensity 
of the separated H4R-specific mRNA bands varied considerably from one sample to another, 
suggesting differences in cellular concentrations of H4R between patients. 
 
 
Fig. 1. Expression of mRNAs specific to 4 subtypes of histamine receptor (H1R, H2R, H3R, 
and H4R) in HSCC from 2 patients with RA. The gel was loaded with 5 µL of amplified 
products. A 100-bp DNA ladder was used as a molecular weight marker. S: standard; C: 
control; samples from 2 RA patients, RA1 and RA2. Figure reprinted with permission from 
the Pharmaceutical Society of Japan. 
Inflamed synoviocytes consist of 3 cell types: (1) macrophage-like cells; (2) fibroblast-like 
cells; and (3) dendritic cells (Tanaka, 2005). High levels of lymphocyte infiltration have been 
observed in RA compared to other types of arthritis (Fonseca et al., 2005). A variety of cell 
types such as macrophage-like cells, dendritic cells, and granulocytes have also been 
identified in the human RA synovium. As H4R has been reported to be present in immune 
cells, expression of H4R mRNA seems most likely to occur in cells derived from the 
hematopoietic system, such as macrophage-like or dendritic cells from synovial sites. 
Consequently, we examined the protein expression levels of H4R in RA HSCC, and used 
fluorescence immunoassays (Ohki et al., 2007) to determine the types of the cells in which 
expression occurred by identifying co-expression of cell type-specific human proteins: PH 
and CD55 for fibroblast-like cells; CD68 and CD163 for macrophage-like cells; and CD1a 
and CD208 for dendritic cells. 
First, we examined the expression patterns of prolyl-4-hydroxylase (PH) (red) and CD68 
(green) using 2 morphologically distinct cell types we identified in our HSCC: fibroblast-like 
and macrophage-like cells. In similar experiments, no expression of human dendritic cell 
markers (either CD1a or CD208) was detectable. Subsequent assays for fibroblast and 
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macrophage markers showed that human H4R protein is expressed in both fibroblast-like 
and macrophage-like cells in RA synovial tissues (Fig. 3 and Fig. 4). Others have also 
reported identification of H4R in synovial tissue of patients with RA (Grzybowska-
Kowalczyk et al., 2007).  
 
Fig. 2. Expression of H4R-specific mRNA in HSCC from 11 RA patients. The gel was loaded 
with 5 µL of amplified products. A 100-bp DNA ladder was used as a molecular weight 
marker. S: standard; C: control; RE: relative expression; sample from 11 different RA 
patients, RA1 to RA11. RE of mRNA was calculated by normalizing the separated sample 
intensity value, taking that of the corresponding internal control (GAPDH) as 100%. 
Intensity values were measured using an image analyzer (IX81, OLYMPUS). Figure 
reprinted with permission from the Pharmaceutical Society of Japan. 
Next, we focused attention on the expression of H4R mRNA in synovial tissues, and serum 
matrix metalloproteinase-3 (MMP-3) concentration in RA. We found a significant negative 
correlation between H4R expression in synovial tissues and serum MMP-3 concentration, 
but no correlation between MMP-3 and H1R or H2R (Yamaura et al., 2011). These 
observations suggest that H4R is a potential target of novel pharmacotherapeutic agents for 
RA, and H4R functional analysis may be useful in developing such treatments. 
In addition, we detected H4R expression in human cartilage chondrocytes and in a murine 
chondrocytic cell line, ATDC5 (Yamaura et al., in press). Further work is needed to 
determine the expression mechanism and function of H4R on chondrocytes. 
3. Expression of H4R in human skin 
Following detection of H4R expression in synovial tissue, we also analyzed H4R expression 
in human epidermal tissue (Yamaura et al., 2009) and fibroblast cell cultures (Ikawa et al., 
2008). Our immunoassays revealed that H4R is expressed in both human epidermal tissues 
and dermal fibroblasts.  
Keratinocytes are the major constituent of the epidermis. We found that 
immunohistochemical staining showed strong H4R expression in keratin (K)10-positive 
differentiated keratinocytes in the prickle cell and granular layers of the epidermis (Fig. 5a). 
By contrast, H4R was weakly expressed in K14-positive proliferating keratinocytes in the 
basal layer (Fig. 5b).  
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Fig. 3. Co-expression of H4R protein with fibroblast-specific marker proteins. (a) Mouse anti-
PH followed by Cy2-conjugated anti-mouse (green); (b) rabbit anti-H4R followed by Cy3-
conjugated anti-rabbit (red); (c) superposition of a on b; (d) Nomarski phase contrast 
microscopy image (NPCMI); (e) rabbit anti-H4R followed by Cy2-conjugated anti-rabbit 
(green); (f) mouse anti-CD55 followed by Cy3-conjugated anti-mouse (red); (g) 
superposition of e on f; (h) NPCMI. Scale bar: 50 µm. Figure reproduced with permission 
from the Pharmaceutical Society of Japan. 
 
 
Fig. 4. Co-expression of H4R protein with macrophage-specific marker proteins.(a) Mouse 
anti-CD68 followed by Cy2-conjugated anti-mouse (green); (b) rabbit anti-H4R followed by 
Cy3-conjugated anti-rabbit (red); (c) superposition of a on b; (d) NPCMI; (e) mouse anti-
CD163 followed by Cy2-conjugated anti-mouse (green); (f) rabbit anti-H4R followed by Cy3-
conjugated anti-rabbit (red); (g) superposition of e on f; (h) NPCMI. Scale bar: 50 µm. Figure 
reproduced with permission from the Pharmaceutical Society of Japan. 
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Fig. 5. H4R expression in human epidermal tissues. Double immunofluorescence staining of 
human epidermal tissues with anti-human H4R antibody followed by Cy2-conjugated anti-
rabbit secondary antibody (red), and anti-K10 (a) or anti-K14 (b) antibody followed by Cy2-
conjugated anti-mouse secondary antibody (green). (c) For the negative control, tissues were 
only exposed to the secondary antibody. Figure reprinted with permission from the 
Japanese Society of Toxicology. 
Keratinization is the result of keratinocytes dividing in the basal lamina and moving to the 
upper layer as they mature. K10 is expressed in keratinocytes in the early stages following 
differentiation, whereas K14 is expressed in undifferentiated keratinocytes. Accordingly, our 
results suggest that keratinocytes increase expression of H4R following differentiation; 
however, further work is necessary to determine the expression mechanism and the 
physiological role of the receptors.  
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Increased H4R expression has been reported in CD4+ T cells of patients with atopic 
dermatitis (Gutzmer et al., 2009), and skin mast cells have been shown to express H4R 
(Lippert et al., 2004). These findings suggest that dermal cells may play an important role, 
via H4R, in skin disorders. Dermal fibroblasts are a major component of the dermis. When 
the skin is damaged, they perform important roles including production of extracellular 
matrix molecules such as collagens. We have demonstrated the expression of H4R in human 
dermal fibroblast cells using immunohistochemical staining (Fig. 6). Furthermore, Western 
blot analysis showed enhancement of the expression level of H4R in dermal fibroblasts by 
stimulation with dexamethasone (Fig. 7). 
 
 
Fig. 6. Expression of H4R on human dermal fibroblasts.Double immunofluorescence staining 
of dermal fibroblast cells treated with anti-human PH antibody followed by Cy2-conjugated 
anti-mouse secondary antibody (green), and anti-human H4R antibody followed by Cy3-
conjugated anti-rabbit secondary antibody (red). Magnification x 400. Figure reprinted with 
permission from the Japanese Society of Toxicology. 
Ohnishi et al. (2008) reported that the levels of leukotriene B4 receptor 1, which belongs to 
the GPCR family, were up-regulated by dexamethasone. This suggests that H4R, which is 
part of the same family, may be up-regulated by dexamethasone too. This up-regulation of 
H4R expression might be associated with itching that occurs as a rebound phenomenon after 
withdrawal of high-dose topical glucocorticoids. We confirmed that significant 
enhancement of pruritus occurred after chronic topical application of dexamethasone in 
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mice (Yamaura et al., 2011). However, further study is needed to investigate the relationship 
between the expression of H4R in skin and pruritus, which are both enhanced by 
dexamethasone. 
 
 
Fig. 7. Effects of dexamethasone on H4R protein expression in human dermal fibroblast cell 
cultures. Expression of H4R was analyzed by Western blot analysis. Protein levels of H4R 
were normalized to the corresponding β-actin protein levels. The mean value of the non-
treatment group was set to 1.0. Data are expressed as means (n=2–3). Figure reprinted with 
permission from the Japanese Society of Toxicology. 
4. Effect of H4R antagonists on pruritus model 
Chronic pruritus, associated with chronic conditions such as skin, liver, and kidney diseases 
and metabolic disorders, is a major diagnostic and therapeutic problem and can have a 
profound impact on the quality of life of patients. Recent studies have raised the possibility 
that H4R, in addition to the H1R, may contribute to histamine-mediated pruritic responses in 
mice (Bell et al., 2004). Both specific H4R agonists and histamine were shown to induce 
pruritic responses which could be blocked by pretreatment with H4R antagonists; the 
response was also found to be markedly attenuated in H4R-deficient mice. We thus 
examined the effectiveness of selective H4R antagonists as antipruritic drugs by their effect 
on histamine H1R antagonist-resistant acute pruritus induced by substance P in mice. 
We investigated the effect of the H1R antagonist fexofenadine and the H4R antagonist 
JNJ7777120 on histamine-induced acute pruritus (Yamaura et al., 2009). Oral administration of 
fexofenadine caused a slight reduction in scratching, whereas JNJ7777120 showed a significant 
reduction (Fig. 8). We then examined the effect of these antagonists in substance P-mediated 
acute pruritus. Fexofenadine showed no reduction in substance P-induced scratching. By 
contrast, JNJ7777120 at 10 and 30 mg/kg doses reduced substance P-induced scratching in a 
dose-dependent manner (Fig. 9). Although JNJ7777120 crosses the blood–brain barrier, it does 
not cause sedation in rodents (Dunford et al., 2007); hence its antipruritic action is not a 
secondary effect of sedation. The results suggest that H1R has only limited involvement in 
histamine-induced pruritus. By contrast, the significant effect of JNJ7777120 suggests that H4R 
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has a much greater role. Substance P-induced pruritus is resistant to H1R antagonists (Togashi 
et al., 2002); given its occurrence in mast cell-deficient mice (Andoh et al., 2001), histamine 
from mast cells is unlikely to be involved. The role of H1R is also thought to be minor, with 
fexofenadine having no observable effect. However, the suppression of the pruritic response 
by JNJ7777120 suggests that histamine may act via H4R rather than H1R. 
 
Fig. 8. Effect of H4R on scratching behavior induced by histamine.Histamine (300 nmol) was 
injected intradermally into shaved skin on the back of each mouse. Immediately after the 
injection of pruritogen, scratching events were counted for 30 min using the MicroAct 
apparatus (Neuroscience Inc., Tokyo, Japan). Fexofenadine (a) or JNJ7777120 (b) was 
administered orally 20 min before the injection of pruritogen. Values represent the mean ± 
SEM of four mice. *p<0.05 vs. control (Dunnett’s multiple comparisons). Figure reprinted 
with permission from the Japanese Society of Toxicology. 
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Fig. 9. Effect of H4R on scratching behavior induced by substance P. Substance P (100 nmol) 
was injected intradermally into shaved skin on the back of each mouse. Immediately after 
the injection of pruritogen, scratching events were counted for 30 min using MicroAct. 
Fexofenadine (a) or JNJ7777120 (b) was administered orally 20 min before the injection of 
pruritogen. Values represent the mean ± SEM of four mice. *p<0.05 vs. control (Dunnett’s 
multiple comparisons). Figure reprinted with permission from the Japanese Society of 
Toxicology. 
Further, we created a chronic itch model in which repeated application of 2,4,6-
trinitrochlorobenzene to the back skin of HR-1 mice was seen to elicit frequent scratching 
behavior at 24 h after challenge. JNJ7777120 at 10 and 30 mg/kg doses reduced this 
scratching behavior, whereas fexofenadine had no such effect (Suwa et al., 2011). These 
results suggest that H4R antagonists may be useful for treatment of H1R antagonist-resistant 
chronic pruritus such as atopic dermatitis. 
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5. Conclusion 
We have demonstrated the expression of H4R in human synovial cells from patients with 
RA and found a significant negative correlation between H4R expression in RA synovial 
tissues and serum MMP-3 concentration. Furthermore, we have shown expression of H4R in 
human skin and demonstrated that an H4R antagonist ameliorates both H1R antagonist-
resistant acute and chronic pruritus. Taken together, these results suggest that histamine 
H4R could be a new drug target for therapeutic use in RA or pruritic skin disorders such as 
atopic dermatitis. 
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